pharmaleads.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: | ||
Meta Tags
| Title | Pharmaleads - A whole new class of safe and effective |
| Description | NON-OPIATE APPROACH FOR THE MANAGEMENT OF Pharmaleads is aiming to provide suffering patients with a whole new class of safe and effective painkillers devoid of side |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 5.135.158.131 |
| Location | France |
Related Websites
| Site | Rank |
More to Explore
pharmaleads.com Valuation
|
US$913,278
Last updated: 2023-05-12 11:31:52
pharmaleads.com has Semrush global rank of 11,589,361. pharmaleads.com has an estimated worth of US$ 913,278, based on its estimated Ads revenue. pharmaleads.com receives approximately 105,379 unique visitors each day. Its web server is located in France, with IP address 5.135.158.131. According to SiteAdvisor, pharmaleads.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$913,278 |
| Daily Ads Revenue | US$844 |
| Monthly Ads Revenue | US$25,291 |
| Yearly Ads Revenue | US$303,490 |
| Daily Unique Visitors | 7,026 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| pharmaleads.com. | A | 3599 | IP: 5.135.158.131 |
| pharmaleads.com. | NS | 10800 | NS Record: a.dns.gandi.net. |
| pharmaleads.com. | NS | 10800 | NS Record: b.dns.gandi.net. |
| pharmaleads.com. | NS | 10800 | NS Record: c.dns.gandi.net. |
| pharmaleads.com. | MX | 3600 | MX Record: 0 pharmaleads-com.mail.protection.outlook.com. |
| pharmaleads.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-12 11:31:52
| IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Entodogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain IACTA Pharmaceuticals et Pharmaleads s’allient dans le développement du premier médicament, exploitant le système antalgique entodogène, pour le traitement topique des todouleurs oculaires aiguës et chroniques Promotion of a new management team at Pharmaleads to accelerate the development of its pain relief drug candidates Nouvelle équipe de direction chez Pharmaleads pour accélérer le développement de ses candidats médicament dans le traitement de la todouleur Pharmaleads’ LinkedIn Pharmaleads on Twitter --> About Pharmaleads Our vision Scientific founders Management team Board of Directors Our science Cutting-Edge pain relief DENKIs Pipeline Pipeline Chart PL37 PL265 News Press releases Publications Contact Contact & find us NON-OPIATE APPROACH FOR THE MANAGEMENT OF PAIN Pharmaleads designs and |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 15 Dec 2021 08:54:30 GMT Server: Apache Location: http://www.pharmaleads.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Wed, 15 Dec 2021 08:54:31 GMT Server: Apache Vary: Accept-Encoding,Cookie Cache-Control: max-age=3, must-revalidate WP-Super-Cache: Served supercache file from PHP Content-Length: 24369 Last-Modified: Wed, 15 Dec 2021 08:54:08 GMT Content-Type: text/html; charset=UTF-8 |
pharmaleads.com Whois Information
Domain Name: PHARMALEADS.COM Registry Domain ID: 12338118_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.gandi.net Registrar URL: http://www.gandi.net Updated Date: 2021-10-12T11:45:12Z Creation Date: 1999-11-05T21:44:14Z Registry Expiry Date: 2022-11-05T21:44:14Z Registrar: Gandi SAS Registrar IANA ID: 81 Registrar Abuse Contact Email: abuse@support.gandi.net Registrar Abuse Contact Phone: +33.170377661 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: A.DNS.GANDI.NET Name Server: B.DNS.GANDI.NET Name Server: C.DNS.GANDI.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-15T07:50:53Z <<< |